Diets containing various docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA) ratios
protect against liver damage in mice fed with a high‐fat diet (HFD). However, it is unclear …

Background A sedentary lifestyle and poor diet are risk factors for the progression of non-
alcoholic fatty liver disease. However, the pathogenesis of hepatic lipid accumulation is not …

Obesity is a recognized epidemic worldwide, and the accumulation of excess free saturated
fatty acids (SFAs) in cells induces cellular lipotoxic damage and increases the risk of a wide …

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …

Hepatic steatosis, an early stage of non-alcoholic fatty liver disease, is commonly present in
obesity and type 2 diabetes, and is associated with reduced hepatic omega-3 …

High-fat-diet (HFD) feeding is associated with liver oxidative stress (OS), n-3 long-chain
polyunsaturated fatty acid (n-3 LCPUFA) depletion, hepatic steatosis and mitochondrial …

Objective: Insulin resistance (IR) is linked to the development of diabetes, non-alcoholic fatty
liver disease (NAFLD), and cardiovascular disease (CVDs). Docosahexaenoic acid (DHA) …

Background Low hepatic content of n-3 PUFA has been associated with NAFLD in humans.
Whether this is associated with reduced dietary intake or increased turnover of these FA is …

Omega-3 (n-3) long-chain polyunsaturated fatty acids (n-3 LCPUFA) are associated with
several physiological functions, suggesting that their administration may prevent non …

The administration of a sodium cholate-supplemented high-fat (CAHF) diet in mice induced
the predominant accumulation of cholesterol esters (CE) in the liver and biochemical and …